title: Systemic listeriosis with adalimumab therapy.
authors.affiliation: Department of Rheumatology, Cork University Hospital, Wilton, Cork, Ireland. grainne.murphy@ucc.ie
authors.forename: Grainne
authors.initials: G
authors.lastname: Murphy
authors.forename: Daniel
authors.initials: D
authors.lastname: Schmidt-Martin
authors.forename: Brian Gerard
authors.initials: BG
authors.lastname: Hynes
authors.forename: Sinead
authors.initials: S
authors.lastname: Harney
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D015994:Incidence; D008089:Listeria monocytogenes; D008088:Listeriosis / Q000453:epidemiology*; D008875:Middle Aged; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab